Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care

Abstract Background As heart failure (HF) still has a similar prognosis to some of the most common cancers, a timely diagnosis of HF is of paramount importance. We sought to determine whether a mobile phone app can facilitate screening for HF in primary care. Material and methods The national echoca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2024-10, Vol.45 (Supplement_1)
Hauptverfasser: Trifunovic-Zamaklar, D, Mladenovic, Z, Stefanovic, M, Tadic, S, Apostolovic, S, Maric Kocijancic, J, Vranic, I, Petrovic, O, Milic, G, Milovancev, A, Filipovic, T, Popovic, M, Paunovic, I, Neskovic, A N, Stankovic, I
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page
container_title European heart journal
container_volume 45
creator Trifunovic-Zamaklar, D
Mladenovic, Z
Stefanovic, M
Tadic, S
Apostolovic, S
Maric Kocijancic, J
Vranic, I
Petrovic, O
Milic, G
Milovancev, A
Filipovic, T
Popovic, M
Paunovic, I
Neskovic, A N
Stankovic, I
description Abstract Background As heart failure (HF) still has a similar prognosis to some of the most common cancers, a timely diagnosis of HF is of paramount importance. We sought to determine whether a mobile phone app can facilitate screening for HF in primary care. Material and methods The national echocardiographic society conducted a multicenter screening programme for HF in which general practitioners from 13 primary care centres used a mobile phone app to decide whether patients without a prior HF diagnosis should be referred to one of the 6 university hospitals for transthoracic echocardiography (TTE) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing. The app would recommend further testing (TTE and NT-proBNP) to patients with symptoms potentially associated with HF, atrial fibrillation, pathologic electrocardiogram (ECG), previous myocardial infarction or exposure to cardiotoxic cancer therapies, or at least two other risk factors listed in Figure (left panel). Patients with signs of HF were not eligible for the programme. The algorithms proposed in the 2021 ESC guidelines were used to diagnose HF across the entire spectrum of left ventricular ejection fraction (EF). Results Of the 930 screened outpatients (mean age 66±11 years, age range 21-91 years, 61% female), 318 symptomatic patients (34.2%) were diagnosed with new HF (Figure). HF with preserved (HFpEF) was diagnosed more frequently than HF with mildy reduced (HFmrEF) and reduced EF (HFrEF). Heart stress, defined as elevated plasma NT-proBNP in asymptomatic individuals with risk factors irrespective of the presence or absence of structural heart disease or cardiac dysfunction, was found in 22.3% (Figure, right panel). In multivariate regression analysis, advanced age, atrial fibrillation, pathological ECG, long-standing history of arterial hypertension and chronic kidney disease were independently associated with HF, while other risk factors were not (Figure, middle panel). Conclusions Screening in primary care based on symptoms and risk factors, facilitated by a mobile phone app, resulted in a new HF diagnosis in approximately one third of screened patients, with the majority of them having HFpEF. Recalibration of the referral criteria might further improve the performance of the app for screening purposes.
doi_str_mv 10.1093/eurheartj/ehae666.950
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_eurheartj_ehae666_950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurheartj/ehae666.950</oup_id><sourcerecordid>10.1093/eurheartj/ehae666.950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c870-6a2d9e9451f9eb9d863b40649b5449f887b0216ca4d3bb94509681ba74831f473</originalsourceid><addsrcrecordid>eNqNkMtqwzAQRUVpoWnaTyjoB5yMbGksLUvoCwLdpNCdkexRo-DYRnIW-fu6rem6q4HhnjvDYexewEqAKdZ0inuycTysaW8JEVdGwQVbCJXnmUGpLtkChFEZov64ZjcpHQBAo8AFs-9jaMN45r3nx96Flviw7zvidhgym1JIIzU81ZGoC90n933kP8e4t6E9xSnYNfMmjZFS4qHjQwxHG8-8tpFu2ZW3baK7eS7Z7ulxt3nJtm_Pr5uHbVbrEjK0eWPISCW8IWcajYWTgNI4JaXxWpcOcoG1lU3h3JQDg1o4W0pdCC_LYsnUb20d-5Qi-Wp-ohJQfWuq_jRVs6Zq0jRx8Mv1p-GfyBexYHFG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Trifunovic-Zamaklar, D ; Mladenovic, Z ; Stefanovic, M ; Tadic, S ; Apostolovic, S ; Maric Kocijancic, J ; Vranic, I ; Petrovic, O ; Milic, G ; Milovancev, A ; Filipovic, T ; Popovic, M ; Paunovic, I ; Neskovic, A N ; Stankovic, I</creator><creatorcontrib>Trifunovic-Zamaklar, D ; Mladenovic, Z ; Stefanovic, M ; Tadic, S ; Apostolovic, S ; Maric Kocijancic, J ; Vranic, I ; Petrovic, O ; Milic, G ; Milovancev, A ; Filipovic, T ; Popovic, M ; Paunovic, I ; Neskovic, A N ; Stankovic, I</creatorcontrib><description>Abstract Background As heart failure (HF) still has a similar prognosis to some of the most common cancers, a timely diagnosis of HF is of paramount importance. We sought to determine whether a mobile phone app can facilitate screening for HF in primary care. Material and methods The national echocardiographic society conducted a multicenter screening programme for HF in which general practitioners from 13 primary care centres used a mobile phone app to decide whether patients without a prior HF diagnosis should be referred to one of the 6 university hospitals for transthoracic echocardiography (TTE) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing. The app would recommend further testing (TTE and NT-proBNP) to patients with symptoms potentially associated with HF, atrial fibrillation, pathologic electrocardiogram (ECG), previous myocardial infarction or exposure to cardiotoxic cancer therapies, or at least two other risk factors listed in Figure (left panel). Patients with signs of HF were not eligible for the programme. The algorithms proposed in the 2021 ESC guidelines were used to diagnose HF across the entire spectrum of left ventricular ejection fraction (EF). Results Of the 930 screened outpatients (mean age 66±11 years, age range 21-91 years, 61% female), 318 symptomatic patients (34.2%) were diagnosed with new HF (Figure). HF with preserved (HFpEF) was diagnosed more frequently than HF with mildy reduced (HFmrEF) and reduced EF (HFrEF). Heart stress, defined as elevated plasma NT-proBNP in asymptomatic individuals with risk factors irrespective of the presence or absence of structural heart disease or cardiac dysfunction, was found in 22.3% (Figure, right panel). In multivariate regression analysis, advanced age, atrial fibrillation, pathological ECG, long-standing history of arterial hypertension and chronic kidney disease were independently associated with HF, while other risk factors were not (Figure, middle panel). Conclusions Screening in primary care based on symptoms and risk factors, facilitated by a mobile phone app, resulted in a new HF diagnosis in approximately one third of screened patients, with the majority of them having HFpEF. Recalibration of the referral criteria might further improve the performance of the app for screening purposes.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehae666.950</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>European heart journal, 2024-10, Vol.45 (Supplement_1)</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Trifunovic-Zamaklar, D</creatorcontrib><creatorcontrib>Mladenovic, Z</creatorcontrib><creatorcontrib>Stefanovic, M</creatorcontrib><creatorcontrib>Tadic, S</creatorcontrib><creatorcontrib>Apostolovic, S</creatorcontrib><creatorcontrib>Maric Kocijancic, J</creatorcontrib><creatorcontrib>Vranic, I</creatorcontrib><creatorcontrib>Petrovic, O</creatorcontrib><creatorcontrib>Milic, G</creatorcontrib><creatorcontrib>Milovancev, A</creatorcontrib><creatorcontrib>Filipovic, T</creatorcontrib><creatorcontrib>Popovic, M</creatorcontrib><creatorcontrib>Paunovic, I</creatorcontrib><creatorcontrib>Neskovic, A N</creatorcontrib><creatorcontrib>Stankovic, I</creatorcontrib><title>Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care</title><title>European heart journal</title><description>Abstract Background As heart failure (HF) still has a similar prognosis to some of the most common cancers, a timely diagnosis of HF is of paramount importance. We sought to determine whether a mobile phone app can facilitate screening for HF in primary care. Material and methods The national echocardiographic society conducted a multicenter screening programme for HF in which general practitioners from 13 primary care centres used a mobile phone app to decide whether patients without a prior HF diagnosis should be referred to one of the 6 university hospitals for transthoracic echocardiography (TTE) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing. The app would recommend further testing (TTE and NT-proBNP) to patients with symptoms potentially associated with HF, atrial fibrillation, pathologic electrocardiogram (ECG), previous myocardial infarction or exposure to cardiotoxic cancer therapies, or at least two other risk factors listed in Figure (left panel). Patients with signs of HF were not eligible for the programme. The algorithms proposed in the 2021 ESC guidelines were used to diagnose HF across the entire spectrum of left ventricular ejection fraction (EF). Results Of the 930 screened outpatients (mean age 66±11 years, age range 21-91 years, 61% female), 318 symptomatic patients (34.2%) were diagnosed with new HF (Figure). HF with preserved (HFpEF) was diagnosed more frequently than HF with mildy reduced (HFmrEF) and reduced EF (HFrEF). Heart stress, defined as elevated plasma NT-proBNP in asymptomatic individuals with risk factors irrespective of the presence or absence of structural heart disease or cardiac dysfunction, was found in 22.3% (Figure, right panel). In multivariate regression analysis, advanced age, atrial fibrillation, pathological ECG, long-standing history of arterial hypertension and chronic kidney disease were independently associated with HF, while other risk factors were not (Figure, middle panel). Conclusions Screening in primary care based on symptoms and risk factors, facilitated by a mobile phone app, resulted in a new HF diagnosis in approximately one third of screened patients, with the majority of them having HFpEF. Recalibration of the referral criteria might further improve the performance of the app for screening purposes.</description><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNkMtqwzAQRUVpoWnaTyjoB5yMbGksLUvoCwLdpNCdkexRo-DYRnIW-fu6rem6q4HhnjvDYexewEqAKdZ0inuycTysaW8JEVdGwQVbCJXnmUGpLtkChFEZov64ZjcpHQBAo8AFs-9jaMN45r3nx96Flviw7zvidhgym1JIIzU81ZGoC90n933kP8e4t6E9xSnYNfMmjZFS4qHjQwxHG8-8tpFu2ZW3baK7eS7Z7ulxt3nJtm_Pr5uHbVbrEjK0eWPISCW8IWcajYWTgNI4JaXxWpcOcoG1lU3h3JQDg1o4W0pdCC_LYsnUb20d-5Qi-Wp-ohJQfWuq_jRVs6Zq0jRx8Mv1p-GfyBexYHFG</recordid><startdate>20241028</startdate><enddate>20241028</enddate><creator>Trifunovic-Zamaklar, D</creator><creator>Mladenovic, Z</creator><creator>Stefanovic, M</creator><creator>Tadic, S</creator><creator>Apostolovic, S</creator><creator>Maric Kocijancic, J</creator><creator>Vranic, I</creator><creator>Petrovic, O</creator><creator>Milic, G</creator><creator>Milovancev, A</creator><creator>Filipovic, T</creator><creator>Popovic, M</creator><creator>Paunovic, I</creator><creator>Neskovic, A N</creator><creator>Stankovic, I</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20241028</creationdate><title>Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care</title><author>Trifunovic-Zamaklar, D ; Mladenovic, Z ; Stefanovic, M ; Tadic, S ; Apostolovic, S ; Maric Kocijancic, J ; Vranic, I ; Petrovic, O ; Milic, G ; Milovancev, A ; Filipovic, T ; Popovic, M ; Paunovic, I ; Neskovic, A N ; Stankovic, I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c870-6a2d9e9451f9eb9d863b40649b5449f887b0216ca4d3bb94509681ba74831f473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trifunovic-Zamaklar, D</creatorcontrib><creatorcontrib>Mladenovic, Z</creatorcontrib><creatorcontrib>Stefanovic, M</creatorcontrib><creatorcontrib>Tadic, S</creatorcontrib><creatorcontrib>Apostolovic, S</creatorcontrib><creatorcontrib>Maric Kocijancic, J</creatorcontrib><creatorcontrib>Vranic, I</creatorcontrib><creatorcontrib>Petrovic, O</creatorcontrib><creatorcontrib>Milic, G</creatorcontrib><creatorcontrib>Milovancev, A</creatorcontrib><creatorcontrib>Filipovic, T</creatorcontrib><creatorcontrib>Popovic, M</creatorcontrib><creatorcontrib>Paunovic, I</creatorcontrib><creatorcontrib>Neskovic, A N</creatorcontrib><creatorcontrib>Stankovic, I</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trifunovic-Zamaklar, D</au><au>Mladenovic, Z</au><au>Stefanovic, M</au><au>Tadic, S</au><au>Apostolovic, S</au><au>Maric Kocijancic, J</au><au>Vranic, I</au><au>Petrovic, O</au><au>Milic, G</au><au>Milovancev, A</au><au>Filipovic, T</au><au>Popovic, M</au><au>Paunovic, I</au><au>Neskovic, A N</au><au>Stankovic, I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care</atitle><jtitle>European heart journal</jtitle><date>2024-10-28</date><risdate>2024</risdate><volume>45</volume><issue>Supplement_1</issue><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Abstract Background As heart failure (HF) still has a similar prognosis to some of the most common cancers, a timely diagnosis of HF is of paramount importance. We sought to determine whether a mobile phone app can facilitate screening for HF in primary care. Material and methods The national echocardiographic society conducted a multicenter screening programme for HF in which general practitioners from 13 primary care centres used a mobile phone app to decide whether patients without a prior HF diagnosis should be referred to one of the 6 university hospitals for transthoracic echocardiography (TTE) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing. The app would recommend further testing (TTE and NT-proBNP) to patients with symptoms potentially associated with HF, atrial fibrillation, pathologic electrocardiogram (ECG), previous myocardial infarction or exposure to cardiotoxic cancer therapies, or at least two other risk factors listed in Figure (left panel). Patients with signs of HF were not eligible for the programme. The algorithms proposed in the 2021 ESC guidelines were used to diagnose HF across the entire spectrum of left ventricular ejection fraction (EF). Results Of the 930 screened outpatients (mean age 66±11 years, age range 21-91 years, 61% female), 318 symptomatic patients (34.2%) were diagnosed with new HF (Figure). HF with preserved (HFpEF) was diagnosed more frequently than HF with mildy reduced (HFmrEF) and reduced EF (HFrEF). Heart stress, defined as elevated plasma NT-proBNP in asymptomatic individuals with risk factors irrespective of the presence or absence of structural heart disease or cardiac dysfunction, was found in 22.3% (Figure, right panel). In multivariate regression analysis, advanced age, atrial fibrillation, pathological ECG, long-standing history of arterial hypertension and chronic kidney disease were independently associated with HF, while other risk factors were not (Figure, middle panel). Conclusions Screening in primary care based on symptoms and risk factors, facilitated by a mobile phone app, resulted in a new HF diagnosis in approximately one third of screened patients, with the majority of them having HFpEF. Recalibration of the referral criteria might further improve the performance of the app for screening purposes.</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/eurheartj/ehae666.950</doi></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2024-10, Vol.45 (Supplement_1)
issn 0195-668X
1522-9645
language eng
recordid cdi_crossref_primary_10_1093_eurheartj_ehae666_950
source Oxford University Press Journals All Titles (1996-Current)
title Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A42%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utility%20of%20mobile%20phone%20app-assisted%20screening%20for%20heart%20failure%20and%20heart%20stress%20in%20primary%20care&rft.jtitle=European%20heart%20journal&rft.au=Trifunovic-Zamaklar,%20D&rft.date=2024-10-28&rft.volume=45&rft.issue=Supplement_1&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehae666.950&rft_dat=%3Coup_cross%3E10.1093/eurheartj/ehae666.950%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/eurheartj/ehae666.950&rfr_iscdi=true